Home/Hedge Fund Intelligence/X4 Pharmaceuticals, Inc
Nasdaq: XFORStockForm 13F30 Jun 2026

Hedge funds that hold X4 Pharmaceuticals, Inc New Nasdaq: XFOR

New · CUSIP 98420X202 · who reports it, how much, and how much it matters to them

10 of the 720 hedge fund managers we track reported shares of X4 Pharmaceuticals, Inc (Nasdaq: XFOR) on Form 13F for 30 June 2026. Between them they reported USD 113m. The largest position belongs to Perceptive Advisors, at USD 37m. The manager with the most riding on it is Empery Asset Management, where it is 37.4% of the reported book.

Managers reporting it10of 720 we track
Value they reportUSD 113mshares only, 30 Jun 2026
Funds they run106with a file on PPLI.com
Largest positionUSD 37mPerceptive Advisors
Typical weight0.2%median share of a manager's book
Heaviest weight37.4%Empery Asset Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

10 managers, USD 113m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports X4 Pharmaceuticals, Inc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Perceptive Advisors6 funds on PPLI.comUSD 37m0.6%
2Empery Asset Management5 funds on PPLI.comUSD 32m37.4%
3Deep Track Capital1 fund on PPLI.comUSD 27m0.4%
4Braidwell12 funds on PPLI.comUSD 14m0.5%
5Verdad Advisers6 funds on PPLI.comUSD 1.6m1.6%
6Squarepoint Ops7 funds on PPLI.comUSD 313,0000.0%
7POINT72 Asset Management17 funds on PPLI.comUSD 192,0000.0%
8Two Sigma Investments35 funds on PPLI.comUSD 90,7190.0%
9Renaissance Technologies13 funds on PPLI.comUSD 84,5270.0%
10Bleichroeder4 funds on PPLI.comUSD 2,7790.0%
Next: where it matters most
Where it matters most

For Empery Asset Management it is 37.4% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Empery Asset ManagementUSD 32m37.4%
2Verdad AdvisersUSD 1.6m1.6%
3Perceptive AdvisorsUSD 37m0.6%
4BraidwellUSD 14m0.5%
5Deep Track CapitalUSD 27m0.4%
6Squarepoint OpsUSD 313,0000.0%
7POINT72 Asset ManagementUSD 192,0000.0%
8Two Sigma InvestmentsUSD 90,7190.0%
9Renaissance TechnologiesUSD 84,5270.0%
10BleichroederUSD 2,7790.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds X4 Pharmaceuticals, Inc

What is the ticker symbol of X4 Pharmaceuticals, Inc?

X4 Pharmaceuticals, Inc trades under the symbol XFOR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 98420X202.

Which hedge funds own X4 Pharmaceuticals, Inc (Nasdaq: XFOR)?

10 of the 720 hedge fund managers PPLI.com tracks reported X4 Pharmaceuticals, Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Perceptive Advisors (USD 37m), Empery Asset Management (USD 32m), Deep Track Capital (USD 27m), Braidwell (USD 14m) and Verdad Advisers (USD 1.6m).

How many hedge funds hold X4 Pharmaceuticals, Inc?

10 managers in our coverage reported it, and between them they run 106 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on X4 Pharmaceuticals, Inc?

Empery Asset Management, where the position was 37.4% of the reported 13F book at 30 June 2026.

Does this show who is short X4 Pharmaceuticals, Inc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with X4 Pharmaceuticals, Inc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.